

IDEXX tops Q3 estimates and lifts 2026 guidance as rising test intensity and global instrument sales offset softer U.S. veterinary clinic traffic.
You can purchase shares of IDEXX Laboratories (NASDAQ:IDXX) through any online brokerage.
Other companies in IDEXX Laboratories’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
IDEXX Laboratories has a consensus price target of $664.55.
The stock price for IDEXX Laboratories (NASDAQ: IDXX) is $678.695 last updated November 6, 2026 at 11:57 AM EST.
There are no upcoming dividends for IDEXX Laboratories.
IDEXX Laboratories does not have any upcoming earnings scheduled.
There is no upcoming split for IDEXX Laboratories.
IDEXX Laboratories is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the...